Ingevity (NGVT) EPS (Weighted Average and Diluted) (2015 - 2026)

Ingevity (NGVT) has 12 years of EPS (Weighted Average and Diluted) data on file, last reported at $1.66 in Q1 2026.

• EPS (Weighted Average and Diluted) for Q1 2026 came in at $1.66, up 110.13% year-over-year; the trailing twelve-month figure through Mar 2026 was -$3.6 (up 61.78% YoY), and the FY2025 annual result was -$4.61, down 38.02% from the prior year.
• EPS (Weighted Average and Diluted) advanced to $1.66 in Q1 2026 per NGVT's latest filing, from -$2.34 in the prior quarter.
• Over five years, EPS (Weighted Average and Diluted) peaked at $1.98 in Q3 2022 and troughed at -$7.81 in Q2 2024.
• A 5-year average of -$0.54 and a median of $0.69 in 2023 frame the typical range for EPS (Weighted Average and Diluted).
• The sharpest annual moves came in 2022 and 2024: EPS (Weighted Average and Diluted) soared 1900.0% in 2022, then plunged 905.15% in 2024.
• A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.44 in 2022, then slumped by 822.73% to -$3.18 in 2023, then surged by 116.98% to $0.54 in 2024, then slumped by 533.33% to -$2.34 in 2025, then surged by 170.94% to $1.66 in 2026.
• Business Quant data shows NGVT's EPS (Weighted Average and Diluted) at $1.66 in Q1 2026, -$2.34 in Q4 2025, and $1.1 in Q3 2025.